Stem Cells

This book will focus on the principle non-therapeutic ('superior cell tools') applications of stem cell technology, but will also include the emerging field of soluble, regenerative medicines. The scope will be a broad, contemporary review of the current status of the art for stem cell utilities in the biopharmaceutical research sector, with emphasis on technology strengths, challenges to resolve and prospects for future development. It will provide cutting edge opinion from academic and industrial leaders in the sector. The book's objectives include an overview of the fundamental science and technology components that underpin the utilities, an in depth review of the strength of the technology using representative biopharmaceutical pipeline and case studies covering key therapeutic/development areas (oncology, cardio-vascular, neuroscience, safety pharmacology) and prediction of advanced applications (disease modelling, regenerative medicine). The book goes beyond the renowned applications and via inclusion of hot topics such as reprogramming and modelling of tissue function in vitro will conveniently set the scene for further consideration as these fields continue to evolve. The editors collectively have nearly 35 years experience in the biopharmaceutical sector, many spent on direct utilization of stem cells and via current affiliations are balanced in deployment to cover both academic and industrial perspectives. As the industry expands, investments increase and new international entrants and applications into the sector appear, a book reviewing contemporary and anticipating future stem cell utilities will be in major demand as no single review article will adequately cover the whole sector.